T1	condition 14 46	post-mastectomy neuropathic pain
T2	intervention 52 61	memantine
T3	No-of-participants 688 690	40
T4	eligibility 691 737	women with breast cancer undergoing mastectomy
T5	location 764 788	Clermont-Ferrand, France
T6	intervention-participants 821 823	20
T7	control 828 835	placebo
T8	control-participants 841 843	20
T9	duration 865 872	4 weeks
T10	outcome-Measure 1057 1071	pain intensity
